Filing Details
- Accession Number:
- 0000950170-23-042785
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-15 16:09:33
- Reporting Period:
- 2023-08-14
- Accepted Time:
- 2023-08-15 16:09:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1698307 | Hazel Hunt | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-08-14 | 20,455 | $30.89 | 73,146 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $30.85 to $30.99. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.